ArticleAntimicrobial agents and chemotherapy2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
A G S Warrilow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this papertrialcites it